ETFChannel.com

RARE Price Target

Recent RARE Price   RARE Price Target
$69.60 RARE price target higher
+11.95%
$77.92
 As of 2020-05-31
Recent RARE Analyst Ratings Breakdown
  Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong buy ratings: 11 11 11 11
Buy ratings: 1 1 1 1
Hold ratings: 1 1 1 1
Sell ratings: 0 0 0 0
Strong sell ratings: 0 0 0 0
Average rating: 1.19 1.19 1.19 1.19
The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is Strong Sell. For the RARE price target at the top of this page, we present the average RARE target price across the 13 analysts covering RARE, as reported in data provided by Zacks Investment Research via Quandl.com. The median RARE price target (a different metric than the average or mean) was $78.0 as of 2020-05-31, the highest RARE price target in the range was $94.0 while the lowest RARE price target in the range was $66.0, with a standard deviation of $6.981. Get the latest Zacks research report on RARE — FREE

Slideshow 10 ETFs With Most Upside To Analyst Targets
Slideshow Top 25 Broker Analyst Picks of the S&P 500

For ETFs, an interesting consideration with analyst target prices is that reaching the target price makes no difference to the ETF as far as deciding whether to continue to hold the stock. ETFs by nature are passive index-followers, so as long as the stock remains in the index, it doesn't much matter whether analysts find the stock overvalued or undervalued. Below are some of the ETFs that hold RARE at last report:

 ETF   RARE Weight   RARE Amount 
 VTI   0.01%   $106,495,181         
 VB   0.10%   $93,822,499         
 XBI   1.55%   $81,871,094         
 IWM   0.21%   $79,089,700         
 FBT   3.70%   $76,648,710         
 VXF   0.08%   $54,090,869         
 VBK   0.21%   $53,419,395         
 IBB   0.43%   $37,969,080         
 IWO   0.38%   $31,675,124         
 VHT   0.08%   $9,931,758         
List of all 33 ETFs holding RARE »
Company Name: 
Ultragenyx Pharmaceutical Inc
Website: 
www.ultragenyx.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding RARE: 
33
Total Market Value Held by ETFs: 
$649,499,371
Total Market Capitalization: 
$4,090,000,000
% of Market Cap. Held by ETFs: 
15.88%
Quotes delayed 20 minutes

Strong Buy (3.81 out of 4)
78th percentile
(ranked higher than approx. 78% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com

RARE Price Target | www.ETFChannel.com

Copyright © 2010 - 2020, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.